does semaglutide affect getting pregnant Ozempic Pregnancy TLDR on GLP-1 receptor agonists

Published by Cambridge University Press Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of glucose-lowering agents that are approved by the US Food and Drug Administration for the treatment of type 2 diabetes mellitus (T2DM) and obesity, lowering the risk of major adverse cardiovascular events, as well as lowering the risk of worsening kidney disease, kidney failure, and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease.Reference Collins and Costello 1 GLP-1 RAs mimic the effects of endogenous GLP-1, which is an endocrine hormone produced in the L-cells of the intestine.Reference Zheng, Zong and Ma 2 Various metabolic effects have been associated with GLP-1, including stimulation of insulin secretion, inhibition of glucagon secretion, slowing gastric emptying, and increasing satiety.Reference Zheng, Zong and Ma 2 In addition to peripheral metabolic effects associated with GLP-1 RAs, extant literature reports GLP-1 RAs have effects within the central nervous system including improvements in cognitive and reward function, reducing the severity of the disparate domains of suicidality as well as protecting against neurodegeneration.Reference Au, Zheng and Le 3 Reference McIntyre, Rasgon and Goldberg 7 While the putative mechanism of action of GLP-1 RAs mainly focuses on agonism of the GLP-1 receptor, the downstream effects of GLP-1 receptor activation as well as potential off-target effects of GLP-1 RAs remain incompletely understood

Lafferty RA, Flatt PR, Irwin N (2023) GLP-1/GIP analogs: potential impact in the landscape of obesity pharmacotherapy

SIGRIDs Glucose Stabilizer capsules are a science-backed GLP-1 supplement designed to support digestion, post-meal satiety and steady energy as part of a healthy lifestyle

Understanding the potential side effects and how to manage them can help patients continue their treatment with minimal discomfort

I kind of started exploring

Nutrition shifts: Favouring fibre-rich foods, limiting saturated fat load, and maintaining a modest energy deficit (around 500-1,000 kcal/day) can meaningfully reduce lipid-driven insulin resistance over time